EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY-NC-ND 4.0

Reverse‐engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial

Dale Lee, Kim Braly, Mason Nuding, Ian Braly, Courtney Hopp, Heather Twible, Christopher Pope, Hillary S Hayden, Luke Hoffman, Hengqi Zheng, Ghassan Wahbeh, David L Suskind

Journal of Pediatric Gastroenterology and Nutrition · 2024

DOI: 10.1002/jpn3.12196 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2024. Verfasst von Dale Lee und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Inflammatory Bowel Disease Center, Seattle Children's Ho…. Hauptthemen laut MEDLINE: Crohn Disease, Enteral Nutrition, Gastrointestinal Microbiome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wendy and John Evans, Richards Family Foundation, Marco Agenti.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In pediatric Crohn's disease (CD), commercial formulas used as exclusive enteral nutrition (EEN) are effective at inducing remission. This study aims to assess the impact of a whole‐food blended smoothie as EEN on CD activity and the intestinal microbiome.

Methods

A 4‐week prospective trial assessed the impact of EEN with a whole‐food smoothie on newly diagnosed mild‐to‐moderate active pediatric CD. The smoothie with a multivitamin were developed to meet age‐appropriate nutritional requirements. Assessment over 4 weeks included Pediatric Crohn's Disease Activity Index (PCDAI), serum laboratories, fecal calprotectin (FCP), and stool collection for metagenomic shotgun sequencing and microbiota composition analysis. Clinical remission was defined as PCDAI ≤ 10 at week 4.

Results

Ten participants were enrolled with median age 14.5 years, and 8 completed the trial. Baseline mean PCDAI was 26.3 ± 9.1 and mean FCP 1149 ± 718 µg/g. At week 4, 80% of participants achieved clinical remission. FCP decreased by over half in 60% of participants, with FCP below 250 µg/g in 60% and below 100 µg/g in 40%. Microbiome analysis showed a significant increase in species richness over 4 weeks ( p = 0.01). Compared to baseline, the relative abundance at week 2 and at week 4 was significantly increased for Bifidobacterium and Streptococcus and decreased for Blautia ( p < 0.05 for all).

Conclusion

A whole‐food blended smoothie was effective for inducing clinical remission and decreasing FCP in pediatric CD similar to commercial EEN formulas. Further research may give insight into data‐driven whole‐food dietary approaches for CD management. ClinicalTrials.gov NCT03508193.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseEnteral NutritionGastrointestinal MicrobiomeHumansPilot ProjectsFemaleMaleAdolescentProspective StudiesChildFecesRemission InductionFood, FormulatedTreatment OutcomeLeukocyte L1 Antigen Complex

Stichwörter der Autor:innen

dietinflammatory bowel diseasemicrobiometreatmentwhole‐food

Substanzen

Leukocyte L1 Antigen Complex

Autor:innen und Institutionen

  • Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Inflammatory Bowel Disease Center, Seattle Children's Hospital, Seattle, Washington, USA.
  • Department of Chemical Engineering, University of Washington, Seattle, Washington, USA.
  • Division of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington, Seattle, Washington, USA.
  • Department of Microbiology, University of Washington, Seattle, Washington.

Förderung

  • Wendy and John Evans
  • Richards Family Foundation
  • Marco Agenti
  • Nanyang Li

Zitieren

APA

Lee, D., Braly, K., Nuding, M., Braly, I., Hopp, C., Twible, H., Pope, C., Hayden, H. S., Hoffman, L., Zheng, H., Wahbeh, G., & Suskind, D. L. (2024). Reverse‐engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.12196

Vancouver

Lee D, Braly K, Nuding M, Braly I, Hopp C, Twible H, et al. Reverse‐engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial. Journal of Pediatric Gastroenterology and Nutrition. 2024. doi:10.1002/jpn3.12196

BibTeX
@article{Lee2024,
  author = {Lee, Dale and Braly, Kim and Nuding, Mason and Braly, Ian and Hopp, Courtney and Twible, Heather and Pope, Christopher and Hayden, Hillary S and Hoffman, Luke and Zheng, Hengqi and Wahbeh, Ghassan and Suskind, David L},
  title = {Reverse‐engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2024},
  doi = {10.1002/jpn3.12196}
}
Kostenlos starten →